Avantgarde Morpho V2 Vaults  - Live on Base With Rewards!

We’re excited to announce that Avantgarde Finance has launched its Conservative USDC Morpho vaults to Morpho V2, with deployments live on Base.
May 12, 2026
Book a demo of the Enzyme platform
Enzyme is an on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, enabling automated reporting, risk management, administration, governance and operations.

Book a demo now
Book now

We’re excited to announce that Avantgarde Finance has launched its Conservative USDC Morpho vaults to Morpho V2, with deployments live on Base.

This upgrade represents a meaningful step forward for our Morpho curation - delivering improved capital efficiency, and expanded distribution across L2s. As a leading vault curator, Avantgarde remains focused on providing risk-managed, non-custodial yield strategies for on-chain capital. The transition to Morpho V2 allows us to continue that mission with more flexible infrastructure and broader reach.

Why Morpho V2?

Morpho V2 introduces a more expressive and modular vault framework, enabling curators to manage risk and capital allocation with greater precision. For users, this translates into:

  • Improved capital efficiency and market access
  • More transparent and configurable vault design
  • Eligibility for Morpho V2 incentive programs supporting vault migration

Live on Base

In addition to migrating to V2 on Ethereum, we’re pleased to announce that Avantgarde’s Conservative USDC strategy is now live on Base.

Avantgarde USDC Conservative Mainnet

Symbol: AVGUSDCconsb

Loan Token: USDC

Base Address: 0xE34D43CA9152D198B60654868C8cD197196a492f

Base Access link: https://app.morpho.org/base/vault/0xE34D43CA9152D198B60654868C8cD197196a492f/avantgarde-usdc-conservative 

Our Approach

Avantgarde applies a risk-managed approach to Morpho vault curation, balancing yield generation with diversification and capital preservation. Our process leverages on-chain data to define an eligible market universe and inform portfolio construction, ensuring that conservative strategies remain resilient across market conditions.

The move to Morpho V2 strengthens our ability to implement this framework consistently across chains.

What’s Next

We’ll continue expanding our Morpho V2 curation across Ethereum and L2s, exploring new strategies across the risk spectrum as the ecosystem evolves.

If you’re interested in Morpho V2 vaults, Base-native yield strategies, or specific markets you’d like us to explore, we’d love to hear from you.

Let’s talk

Get in touch today to find out more information.
Contact us
Our team will contact you soon to talk about your message.
This is some text inside of a div block.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Book a demo of the Enzyme platform
Enzyme is an on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, enabling automated reporting, risk management, administration, governance and operations.

Book a demo now
Book now